How to Take Pregnenolone: Dosage, Timing and Duration in Research
Pregnenolone is often marketed as a "mother hormone" capable of improving memory, mood and energy. Questions about how much to take, when and for how long are common. Our editorial team explains what clinical research has actually used, why pregnenolone is not a typical supplement, and which safety issues should guide any decision.
What pregnenolone is
Pregnenolone is a steroid made from cholesterol, mainly in the adrenal glands, gonads and brain. It sits at the top of the steroid synthesis pathway: from it, the body produces progesterone, cortisol, aldosterone, DHEA and, further downstream, testosterone and oestrogens. That is why it is sometimes called a "precursor of precursors".
It also acts as a neurosteroid. Pregnenolone and its sulphated form influence receptors in the brain, including GABA-A and NMDA receptors, and they have been studied for effects on memory, mood and the response to cannabinoids. A review by Vallée (2016) summarises this neurological interest.
Natural levels decline with age, which has driven marketing of pregnenolone as an anti-ageing product. However, a fall in a hormone level does not automatically mean that replacing it brings benefits. This lesson has been learnt repeatedly with other hormones, including DHEA.
The key point is that pregnenolone is a hormone, not a nutrient. Its effects depend on how the body converts it, which varies between individuals, sexes and health states.
Legal status and sport
In the United States, pregnenolone is sold as a dietary supplement. In the UK and the European Union, the situation is different: it is not an authorised food supplement ingredient, and products with a hormonal action are generally treated as medicinal. Pregnenolone is not a licensed medicine in the UK, so there is no official product with a regulated dose.
Products bought online from abroad are not checked by the MHRA. Their actual content may not match the label, and there is no guarantee of purity or consistent dosing.
For athletes, caution is essential. DHEA, which is directly downstream from pregnenolone, is explicitly named on the WADA prohibited list among anabolic agents. Steroid precursors are a high-risk category, and an athlete in a tested sport should check any such product with UK Anti-Doping or a sports physician before even considering it.
Because of these factors, our editorial team does not provide a personal dosing plan. Instead, we describe the doses that have been used in published studies so that readers understand the context.
Doses used in clinical studies
Most rigorous research on pregnenolone has been conducted in psychiatry, with the drug used as an add-on to standard treatment. These were supervised trials with blood monitoring, not self-use.
| Study | Population | Daily dose studied | Duration |
|---|---|---|---|
| Marx et al., 2009 | Schizophrenia | Titrated up to 500 mg | 8 weeks |
| Ritsner et al., 2010 | Schizophrenia | 30 mg (and a 200 mg arm) | 8 weeks |
| Brown et al., 2014 | Bipolar depression | Titrated up to 500 mg | 12 weeks |
| Osuji et al., 2010 | Bipolar disorder or schizophrenia with alcohol use | Titrated up to 500 mg | 8 weeks |
Results were mixed. Some trials reported improvements in specific symptoms, such as negative symptoms or depressive scores, while others found little difference from placebo. None led to an approved medical indication.
The trials typically lasted 8 to 12 weeks, which means that long-term safety data in humans are lacking. Doses were usually increased gradually under supervision, and participants had regular hormone and safety blood tests.
Timing and duration: what we know
In clinical studies, pregnenolone was usually given orally, sometimes split into two daily doses. Because it can influence sleep and arousal through neurosteroid pathways, some researchers took this into account when choosing morning or evening administration, but there is no robust evidence that one timing is superior.
Duration is the bigger question. Without long-term trials, nobody can say with confidence what happens with months or years of use. Hormonal precursors may shift the balance of downstream hormones over time, and this cannot be predicted without testing.
Several factors make individual responses unpredictable:
- Conversion to progesterone, cortisol, DHEA or androgens differs between people.
- Men and women may experience different hormonal shifts.
- Age, liver function and existing medicines affect metabolism.
- Product quality varies, especially from unregulated sources.
For these reasons, anyone considering pregnenolone for a health problem should do so only with a doctor who can measure baseline hormones and repeat the tests during use.
Possible side effects and contraindications
Reported side effects in trials were generally mild, but the range of possible effects follows from pregnenolone's role as a hormone precursor. They include acne, oily skin, hair thinning, irritability, insomnia, headache and changes in menstrual cycle. Some people report anxiety or overstimulation.
A theoretical concern applies to people with hormone-sensitive conditions. Because pregnenolone can be converted into oestrogens and androgens, it should be avoided by people with a history of breast, ovarian, uterine or prostate cancer, as well as endometriosis or fibroids, unless a specialist advises otherwise.
Pregnenolone is not suitable during pregnancy or breastfeeding, and it is not appropriate for children and adolescents. It may interact with hormone treatments, including contraceptives and HRT, and with medicines that act on the brain.
If someone is experiencing fatigue, low mood or poor memory, these symptoms deserve proper evaluation. Thyroid problems, anaemia, sleep disorders and depression are common and treatable causes that a supplement cannot address.
Editorial conclusions
Pregnenolone is a steroid hormone precursor and neurosteroid, not an ordinary nutrient, and its effects vary between individuals.
In clinical research, doses ranged from about 30 mg to 500 mg per day for 8 to 12 weeks under supervision, with mixed results and no approved indication.
It is not an authorised supplement or licensed medicine in the UK, and athletes face anti-doping risks, so any use should only be considered with medical guidance and blood testing.
Our editorial team also suggests reading about DHEA and its regulation in sport, how to interpret a basic hormone panel and the evidence behind adaptogens for stress.
References
- Marx CE, Keefe RS, Buchanan RW, et al. Proof-of-concept trial with the neurosteroid pregnenolone targeting cognitive and negative symptoms in schizophrenia. Neuropsychopharmacology. 2009;34(8):1885–1903.
- Ritsner MS, Gibel A, Shleifer T, et al. Pregnenolone and dehydroepiandrosterone as an adjunctive treatment in schizophrenia and schizoaffective disorder: an 8-week, double-blind, randomized, controlled, 2-center, parallel-group trial. J Clin Psychiatry. 2010;71(10):1351–1362.
- Brown ES, Park J, Marx CE, et al. A randomized, double-blind, placebo-controlled trial of pregnenolone for bipolar depression. Neuropsychopharmacology. 2014;39(12):2867–2873.
- Osuji IJ, Vera-Bolaños E, Carmody TJ, Brown ES. Pregnenolone for cognition and mood in dual diagnosis patients. Psychiatry Res. 2010;178(2):309–312.
- Vallée M. Neurosteroids and potential therapeutics: focus on pregnenolone. J Steroid Biochem Mol Biol. 2016;160:78–87.
- World Anti-Doping Agency. World Anti-Doping Code International Standard: Prohibited List 2025. Montreal: WADA; 2025.
